Strumento inattivo

Azioni Conceptus, Inc.

Azioni

Prezzo di chiusura Nasdaq Altri mercati azionari
- ^USD	-

Conceptus, Inc. : Tender offer successful: Bayer acquires majority interest in Conceptus	05/06/13
Conceptus, Inc. : Antitrust clearance obtained for Bayer's acquisition of Conceptus	29/05/13
Conceptus, Inc. : Bayer commences cash tender offer for all outstanding shares of Conceptus, Inc.	07/05/13
Conceptus, Inc. : Law Offices of Howard G. Smith Announces Investigation of Conceptus, Inc.	02/05/13
Conceptus, Inc. : Komlossy Law, P.A. Announces Investigation of Conceptus, Inc.	30/04/13

Settore

	Variaz. 1 gen.	Capi.
BIOMÉRIEUX	-9,74%	11,58 Mrd
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-9,80%	8,21 Mrd
DIASORIN S.P.A.	+5,08%	5,77 Mrd
LANTHEUS HOLDINGS, INC.	+27,84%	5,55 Mrd
AUTOBIO DIAGNOSTICS CO., LTD.	-15,47%	3,83 Mrd
ANDON HEALTH CO., LTD.	+8,47%	2,65 Mrd
10X GENOMICS, INC.	-63,81%	2,36 Mrd
VITROLIFE AB	-9,24%	2,27 Mrd
MYRIAD GENETICS, INC.	+21,21%	2,11 Mrd